Gregory Fraser
Stock Analyst at Truist Securities
(2.67)
# 2,202
Out of 5,043 analysts
39
Total ratings
57.14%
Success rate
15.45%
Average return
Main Sectors:
Stocks Rated by Gregory Fraser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIP ANI Pharmaceuticals | Maintains: Hold | $77 → $90 | $92.83 | -3.05% | 11 | Oct 9, 2025 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $200 → $205 | $138.84 | +47.65% | 2 | Aug 28, 2025 | |
| BHC Bausch Health Companies | Maintains: Hold | $8 → $7 | $6.15 | +13.91% | 2 | Jul 25, 2024 | |
| XAIR Beyond Air | Maintains: Buy | $200 → $160 | $2.10 | +7,519.05% | 6 | Apr 30, 2024 | |
| BTMD biote | Maintains: Buy | $10 → $9 | $2.75 | +227.27% | 2 | Jan 18, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6 → $7 | $10.30 | -32.04% | 4 | Nov 8, 2023 | |
| CORT Corcept Therapeutics | Maintains: Hold | $26 → $29 | $71.05 | -59.18% | 5 | Aug 3, 2023 | |
| NVCR NovoCure | Reiterates: Buy | $95 | $13.42 | +607.90% | 3 | Jun 6, 2023 | |
| EOLS Evolus | Maintains: Buy | $14 → $18 | $7.00 | +157.14% | 2 | May 26, 2023 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $45 → $40 | $24.95 | +60.32% | 2 | May 26, 2023 |
ANI Pharmaceuticals
Oct 9, 2025
Maintains: Hold
Price Target: $77 → $90
Current: $92.83
Upside: -3.05%
Jazz Pharmaceuticals
Aug 28, 2025
Maintains: Buy
Price Target: $200 → $205
Current: $138.84
Upside: +47.65%
Bausch Health Companies
Jul 25, 2024
Maintains: Hold
Price Target: $8 → $7
Current: $6.15
Upside: +13.91%
Beyond Air
Apr 30, 2024
Maintains: Buy
Price Target: $200 → $160
Current: $2.10
Upside: +7,519.05%
biote
Jan 18, 2024
Maintains: Buy
Price Target: $10 → $9
Current: $2.75
Upside: +227.27%
Amneal Pharmaceuticals
Nov 8, 2023
Maintains: Buy
Price Target: $6 → $7
Current: $10.30
Upside: -32.04%
Corcept Therapeutics
Aug 3, 2023
Maintains: Hold
Price Target: $26 → $29
Current: $71.05
Upside: -59.18%
NovoCure
Jun 6, 2023
Reiterates: Buy
Price Target: $95
Current: $13.42
Upside: +607.90%
Evolus
May 26, 2023
Maintains: Buy
Price Target: $14 → $18
Current: $7.00
Upside: +157.14%
Arcutis Biotherapeutics
May 26, 2023
Maintains: Buy
Price Target: $45 → $40
Current: $24.95
Upside: +60.32%